Immix Biopharma (IMMX) Amortizatization of Intangibles (2021 - 2026)
Immix Biopharma's (IMMX) quarterly Amortizatization of Intangibles came in at $39189.0 in Q1 2026, up 86.37% year-on-year from $21027.0 in Q1 2025, and up 1.74% quarter-over-quarter from $38517.0 in Q4 2025.
Immix Biopharma (IMMX) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends
Immix Biopharma has disclosed Amortizatization of Intangibles across 4 years of filings, most recently posting $39189.0 for Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $39189.0, up 86.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $136916.0 (up 65.69% YoY), and the FY2025 annual result was $118754.0, up 44.04% from the prior year.
- Amortizatization of Intangibles came in at $39189.0 for Q1 2026 at Immix Biopharma, up from $38517.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $39189.0 in Q1 2026 to a low of $20416.0 in Q2 2024.
- The 3-year median for Amortizatization of Intangibles is $21027.0 (2025), against an average of $26710.0.
- Across the five-year window, Amortizatization of Intangibles climbed 0.9% in 2025 and surged 86.37% in 2026, its largest moves.
- Immix Biopharma's Amortizatization of Intangibles stood at $20734.0 in 2024, then soared by 85.77% to $38517.0 in 2025, then rose by 1.74% to $39189.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $39189.0 (Q1 2026), $38517.0 (Q4 2025), and $37869.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Immix Biopharma | 467.59 Mn | 467.59 Mn | - | 39,189.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39,189.00 |
| Mar 31, 2026 | 39,189.00 |
| Dec 31, 2025 | 38,517.00 |
| Dec 31, 2025 | 38,517.00 |
| Sep 30, 2025 | 37,869.00 |
| Sep 30, 2025 | 37,869.00 |
| Jun 30, 2025 | 21,341.00 |
| Jun 30, 2025 | 21,341.00 |
| Mar 31, 2025 | 21,027.00 |
| Mar 31, 2025 | 21,027.00 |
| Dec 31, 2024 | 20,734.00 |
| Dec 31, 2024 | 20,734.00 |
| Sep 30, 2024 | 20,457.00 |
| Sep 30, 2024 | 20,457.00 |
| Jun 30, 2024 | 20,416.00 |
| Jun 30, 2024 | 20,416.00 |
| Mar 31, 2024 | 20,840.00 |
| Mar 31, 2024 | 20,840.00 |
| Dec 31, 2021 | 16,619.00 |
| Dec 31, 2021 | 16,619.00 |